Literature DB >> 15083268

Calcium channel function and regulation in beta 1- and beta 2-adrenoceptor transgenic mice.

Katharina Foerster1, Tomas Kaeferstein, Ferdi Groner, Stefan Engelhardt, Jan Matthes, Walter J Koch, Martin J Lohse, Stefan Herzig.   

Abstract

Cardiac effects of catecholamines on the L-type calcium channel depend on beta-adrenoceptor subtype (beta(1)- vs. beta(2)-adrenoceptor). Chronic overexpression of these receptors leads to hypertrophy and early death at moderate (beta(1)) or excessive (beta(2)) levels of overexpression respectively. In order to examine the role of L-type calcium channels in altered cardiomyocyte calcium homeostasis found with beta(1)-adrenoceptor overexpression, and to understand the quantitative differences between beta-adrenoceptor subtypes regarding calcium channel regulation, we examined single channels in myocytes obtained from beta(1)- and beta(2)-adrenoceptor transgenic mice. The effects of the agonist isoproterenol were investigated and compared with acute receptor stimulation in the respective non-transgenic littermates. Channels from beta(1)-adrenoceptor transgenic mice have normal baseline activity, and channel number is not reduced. This contrasts to previous findings with beta(2)-adrenoceptor transgenic mice, where channel activity is depressed. Isoproterenol is unable to stimulate channel activity in both transgenic models. In conclusion, the L-type calcium channel is not likely to be involved in alterations of calcium handling of beta(1)-adrenoceptor transgenic myocytes. Furthermore, chronic beta(1)-adrenoceptor overexpression does not depress channel activity, giving another example of the difference between beta(1)- and beta(2)-adrenoceptor signal transduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083268     DOI: 10.1007/s00210-004-0928-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Protein kinase G reverses all isoproterenol induced changes of cardiac single L-type calcium channel gating.

Authors:  G Klein; H Drexler; F Schröder
Journal:  Cardiovasc Res       Date:  2000-12       Impact factor: 10.787

2.  Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle.

Authors:  F Schröder; R Handrock; D J Beuckelmann; S Hirt; R Hullin; L Priebe; R H Schwinger; J Weil; S Herzig
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

3.  Constitutive activity of the human beta(1)-adrenergic receptor in beta(1)-receptor transgenic mice.

Authors:  S Engelhardt; Y Grimmer; G H Fan; M J Lohse
Journal:  Mol Pharmacol       Date:  2001-10       Impact factor: 4.436

4.  Effects of beta2-adrenergic stimulation on single-channel gating of rat cardiac L-type Ca2+ channels.

Authors:  F Schröder; S Herzig
Journal:  Am J Physiol       Date:  1999-03

5.  G(i) protein-mediated functional compartmentalization of cardiac beta(2)-adrenergic signaling.

Authors:  M Kuschel; Y Y Zhou; H Cheng; S J Zhang; Y Chen; E G Lakatta; R P Xiao
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

6.  Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.

Authors:  Guido Michels; Jan Matthes; Renate Handrock; Ute Kuchinke; Ferdi Groner; Leanne L Cribbs; Alexey Pereverzev; Toni Schneider; Edward Perez-Reyes; Stefan Herzig
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

7.  Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor.

Authors:  S Engelhardt; P Boknik; U Keller; J Neumann; M J Lohse; L Hein
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

8.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.

Authors:  C A Milano; L F Allen; H A Rockman; P C Dolber; T R McMinn; K R Chien; T D Johnson; R A Bond; R J Lefkowitz
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

9.  Quinidine-induced potentiation of cardiovascular effects of nitrendipine: functional aspects and possible molecular mechanisms.

Authors:  S Herzig; J Jischa; A Beinhauer; B Geirhos; K Tacke; R G Hempelmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

10.  Coupling of beta2-adrenoceptor to Gi proteins and its physiological relevance in murine cardiac myocytes.

Authors:  R P Xiao; P Avdonin; Y Y Zhou; H Cheng; S A Akhter; T Eschenhagen; R J Lefkowitz; W J Koch; E G Lakatta
Journal:  Circ Res       Date:  1999 Jan 8-22       Impact factor: 17.367

View more
  3 in total

1.  beta-adrenoceptors and potassium channels.

Authors:  Albert Ferro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-06       Impact factor: 3.000

2.  Lack of Gαi2 leads to dilative cardiomyopathy and increased mortality in β1-adrenoceptor overexpressing mice.

Authors:  Kirsten Keller; Martina Maass; Sara Dizayee; Veronika Leiss; Suvi Annala; Jessica Köth; Wiebke K Seemann; Jochen Müller-Ehmsen; Klaus Mohr; Bernd Nürnberg; Stefan Engelhardt; Stefan Herzig; Lutz Birnbaumer; Jan Matthes
Journal:  Cardiovasc Res       Date:  2015-10-13       Impact factor: 10.787

3.  Cardiac G-protein-coupled receptor kinase 2 ablation induces a novel Ca2+ handling phenotype resistant to adverse alterations and remodeling after myocardial infarction.

Authors:  Philip W Raake; Xiaoying Zhang; Leif E Vinge; Henriette Brinks; Erhe Gao; Naser Jaleel; Yingxin Li; Mingxin Tang; Patrick Most; Gerald W Dorn; Steven R Houser; Hugo A Katus; Xiongwen Chen; Walter J Koch
Journal:  Circulation       Date:  2012-04-10       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.